GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TMC Life Sciences Bhd (XKLS:0101) » Definitions » Cyclically Adjusted Revenue per Share

TMC Life Sciences Bhd (XKLS:0101) Cyclically Adjusted Revenue per Share : RM0.52 (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is TMC Life Sciences Bhd Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

TMC Life Sciences Bhd's adjusted revenue per share for the three months ended in Sep. 2024 was RM0.047. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is RM0.52 for the trailing ten years ended in Sep. 2024.

During the past 12 months, TMC Life Sciences Bhd's average Cyclically Adjusted Revenue Growth Rate was 4.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of TMC Life Sciences Bhd was 5.70% per year. The lowest was 5.70% per year. And the median was 5.70% per year.

As of today (2024-12-14), TMC Life Sciences Bhd's current stock price is RM0.495. TMC Life Sciences Bhd's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was RM0.52. TMC Life Sciences Bhd's Cyclically Adjusted PS Ratio of today is 0.95.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of TMC Life Sciences Bhd was 1.56. The lowest was 0.96. And the median was 1.24.


TMC Life Sciences Bhd Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for TMC Life Sciences Bhd's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TMC Life Sciences Bhd Cyclically Adjusted Revenue per Share Chart

TMC Life Sciences Bhd Annual Data
Trend May14 May15 May16 Aug17 Aug18 Aug19 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.44 0.47 0.49 0.52

TMC Life Sciences Bhd Quarterly Data
Aug19 Nov19 Feb20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.50 0.51 0.52 0.52

Competitive Comparison of TMC Life Sciences Bhd's Cyclically Adjusted Revenue per Share

For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TMC Life Sciences Bhd's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where TMC Life Sciences Bhd's Cyclically Adjusted PS Ratio falls into.



TMC Life Sciences Bhd Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TMC Life Sciences Bhd's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.047/133.0289*133.0289
=0.047

Current CPI (Sep. 2024) = 133.0289.

TMC Life Sciences Bhd Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201408 0.019 100.352 0.025
201411 0.022 99.635 0.029
201502 2.880 99.032 3.869
201505 0.024 100.333 0.032
201508 0.022 100.548 0.029
201511 0.017 100.135 0.023
201602 0.016 100.040 0.021
201605 0.020 101.355 0.026
201608 0.013 101.617 0.017
201611 0.014 101.829 0.018
201702 0.014 102.779 0.018
201705 0.015 103.256 0.019
201708 0.023 103.587 0.030
201711 0.023 104.072 0.029
201802 0.022 105.052 0.028
201805 0.025 106.148 0.031
201808 0.025 106.383 0.031
201811 0.027 106.338 0.034
201902 0.026 106.649 0.032
201905 0.029 108.048 0.036
201908 0.030 108.245 0.037
201911 0.030 108.519 0.037
202002 0.029 109.139 0.035
202009 0.029 109.815 0.035
202012 0.028 109.897 0.034
202103 0.028 111.754 0.033
202106 0.031 114.631 0.036
202109 0.030 115.734 0.034
202112 0.034 117.630 0.038
202203 0.035 121.301 0.038
202206 0.041 125.017 0.044
202209 0.041 125.227 0.044
202212 0.042 125.222 0.045
202303 0.047 127.348 0.049
202306 0.049 128.729 0.051
202309 0.053 129.860 0.054
202312 0.054 129.419 0.056
202403 0.049 131.776 0.049
202406 0.043 132.554 0.043
202409 0.047 133.029 0.047

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


TMC Life Sciences Bhd  (XKLS:0101) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

TMC Life Sciences Bhd's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.495/0.52
=0.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of TMC Life Sciences Bhd was 1.56. The lowest was 0.96. And the median was 1.24.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


TMC Life Sciences Bhd Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of TMC Life Sciences Bhd's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


TMC Life Sciences Bhd Business Description

Traded in Other Exchanges
N/A
Address
No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.

TMC Life Sciences Bhd Headlines

No Headlines